Medicus Pharma Stock (NASDAQ:MDCX)

Financials Chart

Previous Close

$2.39

52W Range

$1.79 - $8.94

50D Avg

$2.33

200D Avg

$3.14

Market Cap

$51.71M

Avg Vol (3M)

$385.23K

Beta

-2.02

Div Yield

-

MDCX Company Profile

Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets, with an emphasis on non-invasive treatments for skin cancer.

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CA

Employees

12

IPO Date

Nov 15, 2024

Website

MDCX Performance

MDCX Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	-	-	-
Operating Income	$-11.18M	$-4.73M	$-978.42K
Net Income	$-10.62M	$-5.31M	$-1.69M
EBITDA	$-10.25M	$-2.66M	$-1.17M
Basic EPS	$-1.10	$-1.53	$-0.88
Diluted EPS	$-1.10	$-1.53	$-0.21

Fiscal year ends in Dec 24 | Currency in USD

Peer Comparison

Ticker	Company
SKYE	Skye Bioscience, Inc.
IPSC	Century Therapeutics, Inc.
IOBT	IO Biotech, Inc.
QTTB	Q32 Bio Inc.
EQ	Equillium, Inc.
CALC	CalciMedica, Inc.
BCAB	BioAtla, Inc.
LTRN	Lantern Pharma Inc.